Arrowpoint Asset Management LLC 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-10-13 06:01 am Sale |
2021-09-30 | 13G | Forte Biosciences, Inc. FBRX |
Arrowpoint Asset Management LLC | 0 0.000% |
-55,783 (Position Closed) |
Filing |
| 2021-04-12 4:17 pm Sale |
2021-03-31 | 13G | Forte Biosciences, Inc. FBRX |
Arrowpoint Asset Management LLC | 55,783 10.320% |
-61,686 (-52.51%) |
Filing |
| 2020-07-10 2:56 pm Purchase |
2020-06-30 | 13G | Forte Biosciences, Inc. FBRX |
Arrowpoint Asset Management LLC | 117,468 27.190% |
117,468 (New Position) |
Filing |